Hui Tzu Chou
Family · Flushing, NYNPI 1659757664
Payments from drug & device makers
Across 282 payments — averaging $32.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$2K
- Amgen$2K
- AbbVie$1K
- Novo Nordisk$896
- Esperion Therapeutics, Inc.$651
- Nestle Healthcare Nutrition Inc.$555
- plus $2K from 10 others
What the payments were for
- Food & beverage$9,224100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 84 | $2,203 |
| Amgen | 47 | $1,887 |
| AbbVie | 35 | $1,105 |
| Novo Nordisk | 34 | $896 |
| Esperion Therapeutics, Inc. | 10 | $651 |
| Nestle Healthcare Nutrition Inc. | 13 | $555 |
| IBSA Pharma Inc. | 13 | $341 |
| Biohaven Pharmaceutical Holding Company Ltd. | 10 | $313 |
| Pfizer | 13 | $254 |
| Amarin Pharma, Inc. | 12 | $233 |
| Phathom Pharmaceuticals, Inc. | 3 | $168 |
| Agepha Pharma FZ LLC | 1 | $154 |
| Madrigal Pharmaceuticals | 1 | $128 |
| Boehringer Ingelheim | 1 | $125 |
| Otsuka America Pharmaceutical, Inc. | 1 | $125 |
| Lilly USA, LLC | 4 | $85 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,224 in reported general payments places this provider in the 95th percentile of 8,883 family providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Epolamine | 511 | $354,998 |
| VascepaIcosapent Ethyl | 813 | $307,456 |
| Evenity (2 Syringes)Romosozumab-Aqqg | 62 | $149,479 |
| VemlidyTenofovir Alafenamide | 88 | $121,930 |
| Diclofenac Sodium | 222 | $110,886 |
| RybelsusSemaglutide | 104 | $105,768 |
| JardianceEmpagliflozin | 150 | $102,008 |
| LinzessLinaclotide | 113 | $64,235 |
| ProliaDenosumab | 25 | $42,401 |
| OzempicSemaglutide | 40 | $37,046 |
| RestasisCyclosporine | 38 | $34,984 |
| CreonLipase/Protease/Amylase | 27 | $34,007 |
| JanuviaSitagliptin Phosphate | 48 | $32,704 |
| EliquisApixaban | 45 | $28,879 |
| FarxigaDapagliflozin Propanediol | 41 | $25,036 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AmgenEvenity (2 Syringes), Prolia | $1,887 | $191,87987 claims |
| AbbVieLinzess, Restasis, Creon, Ubrelvy | $1,105 | $146,914189 claims |
| Novo NordiskRybelsus, Ozempic | $896 | $142,814144 claims |
| GileadVemlidy | $2,203 | $121,93088 claims |
| Boehringer IngelheimJardiance, Tradjenta | $125 | $108,521164 claims |
| PfizerEliquis, Abrysvo | $254 | $34,99568 claims |
| IBSA Pharma Inc.Licart | $341 | $13,35617 claims |
| Esperion Therapeutics, Inc.Nexletol | $651 | $8,21118 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,883 family providers in New York.
Other family in Flushing
- Christina NalboneNew York$197K
- Casey GrilloNew York$191K
- Suzanne WilsonIthaca$179K
- Jonathan LesuerSyracuse$172K
- Sheri HillNorth Syracuse$165K
- Cathrine CurtinBronxville$155K
- Mary Sullivan-WhalenNew York$137K
- Sarah AljahmiRockville Centre$87K
- John de OcaStaten Island$86K
- Fara StrickerGlen Oaks$85K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.